Nasdaq GlobeNewswire

NewLink Genetics Announces Presentation of Abstracts at ASCO 2018 Annual Meeting

NetworkNewsWire Announces Publication on Good News in Biotech Advancements Through Cannabis Delivery Technology

Immune Design to Report First Quarter 2018 Financial Results and Provide Corporate Update

Aptose Announces Appointment of Caroline M. Loewy to Board of Directors

Sharps Compliance Reports Fiscal 2018 Third Quarter Results

Sunniva Inc. to Delay Earnings Release Until April 30, 2018

Icon Media Holdings, Inc. Enters Into Joint Services Agreement with DMR Biologics

Intrommune Therapeutics to Present at Eighth Annual BioNJ BioPartnering Conference

Organovo to Present at 2nd Annual NASH Summit

Catalyst Pharmaceuticals Introduces New Corporate Website

Cytokinetics Announces Presentation of Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy at the 2018 Annual Cure SMA Conference

Axsome Therapeutics Hosts R&D Day Today with Key Opinion Leaders Focusing on AXS-05 and Unmet Needs in Depression, Alzheimer’s Disease Agitation, and Nicotine Dependence

ViaDerma, Inc. Enters into a $250,000 Initial Sales Agreement with Vage Nigeria Ltd.

ProQR Provides Enrollment Update on QR-110 Clinical Trial and Highlights Ophthalmology Presentations at ARVO

Astaxanthin Market worth over $800 million by 2024: Global Market Insights, Inc.

Axsome Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of AXS-05 in Smoking Cessation

NewLink Genetics to Host Its First Quarter 2018 Financial Results Conference Call on May 3, 2018

Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease

NetworkNewsAudio Covers Lexaria’s Biotech Breakthrough in Nicotine Delivery

FDA Accepts Veloxis’s Supplemental New Drug Application for the De Novo Indication for ENVARSUS XR®